key: cord-0764443-e56qhd06 authors: Dessie, Zelalem G.; Zewotir, Temesgen title: Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients date: 2021-08-21 journal: BMC Infect Dis DOI: 10.1186/s12879-021-06536-3 sha: b172465c263493dec2b44d00d6551104161e47cb doc_id: 764443 cord_uid: e56qhd06 BACKGROUND: Mortality rates of coronavirus disease-2019 (COVID-19) continue to rise across the world. The impact of several risk factors on coronavirus mortality has been previously reported in several meta‐analyses limited by small sample sizes. In this systematic review, we aimed to summarize available findings on the association between comorbidities, complications, smoking status, obesity, gender, age and D-dimer, and risk of mortality from COVID-19 using a large dataset from a number of studies. METHOD: Electronic databases including Google Scholar, Cochrane Library, Web of Sciences (WOS), EMBASE, Medline/PubMed, COVID-19 Research Database, and Scopus, were systematically searched till 31 August 2020. We included all human studies regardless of language, publication date or region. Forty-two studies with a total of 423,117 patients met the inclusion criteria. To pool the estimate, a mixed-effect model was used. Moreover, publication bias and sensitivity analysis were evaluated. RESULTS: The findings of the included studies were consistent in stating the contribution of comorbidities, gender, age, smoking status, obesity, acute kidney injury, and D-dimer as a risk factor to increase the requirement for advanced medical care. The analysis results showed that the pooled prevalence of mortality among hospitalized patients with COVID-19 was 17.62% (95% CI 14.26–21.57%, 42 studies and 423,117 patients). Older age has shown increased risk of mortality due to coronavirus and the pooled odds ratio (pOR) and hazard ratio (pHR) were 2.61 (95% CI 1.75–3.47) and 1.31 (95% CI 1.11–1.51), respectively. A significant association were found between COVID-19 mortality and male (pOR = 1.45; 95% CI 1.41–1.51; pHR = 1.24; 95% CI 1.07–1.41), and current smoker (pOR = 1.42; 95% CI 1.01–1.83). Furthermore, risk of mortality among hospitalized COVID-19 patients is highly influenced by patients with Chronic Obstructive Pulmonary Disease (COPD), Cardiovascular Disease (CVD), diabetes, hypertension, obese, cancer, acute kidney injury and increase D-dimer. CONCLUSION: Chronic comorbidities, complications, and demographic variables including acute kidney injury, COPD, diabetes, hypertension, CVD, cancer, increased D-dimer, male gender, older age, current smoker, and obesity are clinical risk factors for a fatal outcome associated with coronavirus. The findings could be used for disease’s future research, control and prevention. The 2019 novel coronavirus (2019-nCoV) is a newly emerging disease that was first reported in China, and has subsequently spread worldwide. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belong to the family of Betacoronavirus genus [1] . Although the clinical presentation and symptoms of COVID-19 are similar to that of Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), the rate of spread is greater [2] . On 11 March 2019, the WHO defined COVID-19 as a pandemic disease [3] , and as of February 2021, a total of 107,496,792 cases and 2,353,308 deaths (3.0%) have been confirmed worldwide in 219 countries [4] . It is a major challenge for many countries to identify what measures could be used to avoid death or severe illness. The challenge of COVID-19 is very high globally due to the complexity of its transmission and a lack of proven treatment [5, 6] . It will be more disastrous for middle and low-income countries because of their high illiteracy, a very poor health care system, and a scarce Intensive Care Unit. A series of studies have reported clinical characteristics of COVID-19 critical illness [7] and severe illness [8] patients. The clinical features and risk factors considered aims for the identification of risk factors associated with fatal outcomes. Regardless of the scientist's effort to better understand the diagnostic, and clinical characteristics of the disease, our current understanding of patient's risk factors of death with COVID-19 is still limited. Accordingly one might not exhaustively study all possible risk factors. In every study, the considered risk factors vary in number and type. Based on the literature review we studied the commonly reported Table 1 Characteristics of studies included in the systematic review and meta-analysis on the effect of comorbidities, gender, age, smoking status, obesity, acute kidney injury, and D-dimer gender on fatal outcome of COVID-19 Authors ( Lee et al. [36] UK 800 226 69 [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] 449 (56) 109 (14) 131 (16) Mikami et al. [32] USA 6493 858 59 [43, 72] Petrilli et al. [29] USA 5279 665 54 risk factors such as hypertension, diabetes, chronic obstructive pulmonary disease, dyspnoea, history of substance use, gender, acute respiratory distress syndrome (ARDS), history of smoking, older age, albumin, and D-dimer [9] [10] [11] [12] . The study aims to synthesize and enhance our understanding about the precision of the risk factors effect on COVID-19 fatality rate. To examine the association between COVID-19 mortality versus in with comorbidities, gender, smoking status, obesity, age, acute kidney injury, and D-dimer, we followed PRISMA guidelines [13] to perform the meta-analysis of the articles identified through our systematic reviews. Electronic databases including Google Scholar, Cochrane Library, Web of Sciences (WOS), EMBASE, Medline/PubMed, COVID-19 Research Database (WHO), COVID-19 Open Research Dataset Challenge, and Scopus, were systematically searched till 31 August 2020. The search strategy was as follows: ("severe acute respiratory syndrome coronavirus 2" or "novel coronavirus" or "COVID-19" or "2019-nCoV" or "SARS-CoV-2") and ("survival" or "fatal outcome" or "mortality" or "death"). Furthermore, the search was specifically focused on articles that analyzed laboratory parameters, pre-existing comorbidities, clinical status, and demographic characteristics as potential predictors for fatal outcome of COVID-19. No restriction was applied on time and language of publications. In order to improve the screening process and save time, we downloaded the literature results into EndNote X9. Once duplicates were removed, the initial search results were screened for relevance by titles and abstracts by both authors. The full texts were reviewed for the eligibility criteria (Fig. 1) . Studies without abstract and/ or full text, Correspondence letters, COVID-19 studies on children only, editorials, reviews, qualitative studies, books, theses, expert opinion papers, and review articles were excluded from the analysis. Furthermore, among the eligible studies, we used if only the study reported odds ratios (ORs) or hazard ratios (HRs) along with 95% CI for the association between demographic or epidemiological or clinical characteristics and fatal outcome of coronavirus. Both authors independently examined the downloaded EndNote X9 search outputs eligibility for inclusion. Any disagreements between the authors were resolved through discussion and mutual agreement. Both authors extracted the following data: the first author's name, countries, assessment methods, sample size, study design, the publication year, demographic variables (e.g., gender, age, etc.), clinical variables (e.g., comorbidities, complications, D-dimer, etc.), outcome (mortality), exposure (risk factors), and adjusted odds ratios or hazard ratios or relative risk. The authors independently evaluated the quality methodological approach of the articles using a Newcastle-Ottawa technique [14] . In this technique, three main components were utilized to assess the quality of the papers such as assessment of the outcome, comparability of the study groups, and selection procedure of the study patients. The Newcastle-Ottawa technique included seven domains, each one of these domains were scored from 3 to 0 (i.e., from low to high bias) and their average score were taken. We have used peer-reviewed and published ORs or HRs (and their 95%CI) for the association between the fatal outcome of COVID-19 and risk factors. A mixed-effect model has been computed keeping into consideration the expected between-study heterogeneity. Heterogeneity in effect sizes was assessed by computing Cochran's Q test; a significant Q indicates a lack of homogeneity and inference of heterogeneity. The proportion of the total variance attributable to the study heterogeneity was determined using I 2 statistic [15] . The I 2 values of 60-90%, 40-59%, and 0-39% were considered to indicate severe, moderate, and mild, respectively [15] . Funnel plots with Egger weighted regression test were used for assessing publication bias [16] . All of the analyses were implemented with the statistical software's R-4.0.2 and We Fig. 1 ). Out of the 42 studies, thirty-nine provided adjusted hazard and odds ratios after multivariate adjustment for the covariates such as comorbidities, gender, smoking status, obesity, age, acute kidney injury, and D-dimer . And the rest three studies provided crude hazard and odds ratios [53] [54] [55] ( Table 1) . Table 1) . The mixed effect meta-analysis model results are presented in Fig. 2 . From this plot, we can see that the mortality rate of coronaviruses among the included studies ranges from a minimum of 3.14 (95% CI 2.34-4.12%) [46] to a maximum of 61.51 (95% CI 55.02-67.71%) [19] . Of the total 423 117 patients, 35 020 died which resulted in a weighted pooled overall mortality prevalence of 17.62% (95% CI, 14.26-21.57%). (Fig. 2) . In the meta-analysis 32 effect sizes of the demographic characteristics were obtained from 37 studies [5, 9-12, 15, 17, 18, 20-22, 28, 29, 38, 40, 47- Fig. 3) . Twenty-four studies evaluated the risk of COVID-19 mortality among male patients and showed a significantly higher risk and the pooled OR and HR were 1.45 (95% CI 1.41-1.51) and 1.24 (95% CI 1.07-1.41), respectively ( Table 2 and Fig. 4 ). Coronavirus related risk of mortality was significantly associated with smoker patients when compared to non-smoker patients, (pOR = 1.42; 95%CI = 1.01-1.83) (Fig. 5B) . Furthermore, the combined 11 effect sizes from 11 studies [2, 10, 21, 22, 24, 28, 31, 40, 44, 51, 56] revealed significant association between obesity and coronaviruses mortality (pOR = 1.34; 95%CI = 1.17-1.52; pHR = 1.50; 95%CI = 1.26-1.75) (Fig. 5A) . A total of 60 effect sizes of comorbidities were extracted from 34 studies [3, 9, 11, 12, 15, 18, 21-24, 27, 28, 31, 39, 40, 44, 48, 50-52, 54-57, 67, 69, 71-73] with a total of 407, 638 patients and 32, 465 death. The association between diabetes and in-hospital mortality are displayed in Table 2 and Fig. 6B . We noted that mortality among hospitalized COVID-19 patients with diabetes was higher compared to the patients without diabetes aOR = 1.52 (95% CI 1.36-1.69) and aHR = 1.17 (95% CI 1.02-1.32). Likewise, risk of mortality among hospitalized COVID-19 patients is highly influenced by patients with COPD (pOR = 1.58; 95% CI 1.08-2.02; pHR = 1.71; 95% CI 1.01-1.40) (Fig. 7B) , hypertension (pOR = 1.57; 95% CI 1.27-1.87; pHR = 1.18; 95% CI 1.01-2.07) (Fig. 7A) , CVD (pOR = 1.83; 95% CI 1.50-2.17) (Fig. 6A ) and cancer (pHR = 1.33; 95% CI 1.09-1.56) (Fig. 8A) . In the meta-analysis of eight effect sizes from eight studies [19, 26, 30, 34, 39, 40, 48, 74] , we noted that a significant positive association between acute kidney injury and COVID-19 mortality and the pooled OR and HR were 1.87 (95% CI 1.48-2.26) and 2.21 (95% CI 1.44-2.99), respectively (Fig. 9A) . But acute cardiac injury association with COVID-19 fatality was not found to be significant (pOR = 2.33; 95% CI 0.88-3.79; pHR = 1.89; 95% CI 0.75-3.02) (Fig. 8B) . Furthermore, the combined effect sizes from six studies [10, 17, 18, 32, 45, 53] revealed a significant association between increase D-dimer and coronaviruses mortality (pOR = 10.49; (Fig. 9B) . The Newcastle-Ottawa score of the included studies was 7-9, and the quality of the articles was evaluated as high (Table 3) . The I 2 statistics for gender, smoking status, obesity, CVDs, COPD, hypertension, cardiac injury, cancer, age, and d-dimer, had shown heterogeneities among the considered studies. From the sensitivity analysis, we noted that the overall estimates of comorbidities, gender, age, smoking status, obesity, acute kidney injury, and D-dimer on the fatal outcome of coronavirus, did not depend on a single study. Funnel plots were plotted for the included studies in the meta-analysis, which suggested that there is no noticeable bias in the studies of our meta-analysis (Fig. 10) . Besides, Begg's correlation rank and egger's regression failed to show significant publication bias (see Table 2 ). The meta-analysis of currently available regional and national reports of patients with coronavirus infection highlights the effect of complications, comorbidities, and demographic variables on mortality of coronavirus. These results have important clinical implications such as on the clinical management and specific preventive measures of coronavirus patients. Our study is by far the largest meta-analysis on COVID-19 fatality study in terms of size and coverage of complications, comorbidities, behavioural and demographic risk factors. We found that smoking was significantly associated with the risk of mortality in coronavirus. Such a result was also reported [64] in a limited scale meta-analysis study. Accordingly, perhaps it is a high time step up effort to advocate the danger of smoking as well as an intervention to stop smoking to reduce the overall disease burden. Reportedly old age was significantly associated with MERS-Cov [66] and SARS [68] mortality. Likewise, our finding showed a significant association of old age with coronavirus mortality. A plausible reason for this might be some age-related chronic medical conditions and/ or lower immunity level [57] . In addition, ageing affects CD4 + T cells, CD8 + T cells, B cells functions [75] . This age-related reduction in T cells and B cells clonal diversity is associated with impaired responses to viral infections such as influenza [76] and the excess production of type 2 cytokines could lead to prolonged pro-inflammatory immune responses and therefore perhaps contribute to poor outcomes [62] . Female with coronavirus have lower rates of hospitalization and mortality than male [77] . The results of our metaanalysis also showed that men seems to be a risk factor for COVID-19 mortality. Sex differences in both the adaptive and innate immune system have been reported previously and may account for the women advantage in coronavirus. Within the adaptive immune system, men have lower numbers of CD8 + T cell [78] , CD4 + T cell [79] and decreased B cell production compared to women [79] . Moreover, since some important immune regulatory genes are located on the X chromosome, women patients might be advantaged due to a higher expression TLR7 [72] . Our systematic review result also confirmed that obesity was associated with death in coronavirus patients. Indeed previously limited scale meta-analysis study [70] had also shown the same findings. From our systematic review, we found that diabetes, CVDs, COPD, hypertension, and acute kidney injury were the significant risk for COVID-19 mortality. These factors were also reported as the coronavirus risk factor by CDC and WHO. With regard to patients' COPD status and COVID-19 mortality association, studies [9] have argued that COPD patients with COVID-19 showed higher rates of hospitalization and mortality. This could be due to viral infections in COPD patients increase systemic inflammation with the slow recovery of reported symptoms [80] . In addition to the influence of coronavirus, COPD patients have various comorbidities, some of which are associated with an increased risk of hospitalization [69] . Diabetes also contributes to more severe COVID-19 and higher rates of mortality [81] . Our analysis also showed that mortality among hospitalized COVID-19 patients with diabetes was higher compared to the patients without diabetes. Thus, patients with diabetes and COVID-19 often need invasive ventilation care and need intensive care unit (ICU) due to their likelihood of developing Acute Respiratory Distress Syndrome (ARDS) [73] . Another two small systematic reviews, by [67, 73] also suggested that diabetes is a determinant of severity and mortality of COVID-19 patients. Having a high D-dimer has shown a significantly increased odds of mortality. Previous study [59] had also shown that a high level of D-dimer increases severe infection and risk of mortality. In addition a study in China [17] have shown that rising D-dimer levels during the course of hospitalization are associated with the worst long-term outcomes. Therefore, using D-dimer levels as a surrogate marker for disease severity, especially, in coronavirus patients who cannot get dedicated imaging might be beneficial. Although this systematic review presented pooled estimate from 42 studies across 13 geographical locations and may be considered broadly representative of the pandemic, our study has a few limitations. First, high heterogeneity could be found. This may relate to large variation in the sample size among studies (98-211,003 patients) and the study designs. Second, the literature on coronavirus continues to accumulate, new information and new papers published each day; therefore, our study cannot be considered as exhaustive. Finally, the sample size of some included studies was very small which might not recognize the possible factors that affects COVID-19 mortality. Our study indicated a consistent and statistically significant effect of chronic comorbidities, complications, and demographic variables including acute kidney injury, COPD, diabetes, hypertension, CVDs, cancer, increased D-dimer, male gender, older age, current smoker, and obesity on the fatal outcome of COVID-19. Urgent public health interventions should be carefully tailored and implemented on those susceptible groups to reduce the risk of mortality in patients with COVID-19 and, then, the risk of major complications. An intensive and regular follow-up is required to detect early occurrences of clinical conditions. Abbreviations ARDS: Acute respiratory distress syndrome; COVID-19: Coronavirus infection pneumonia 2019; MERS: Middle East respiratory syndrome; pHR: Pooled hazard-ratio; pOR: Pooled odds-ratio; PRISMA-P: Preferred reporting Items for systematic reviews and meta-analyses protocols; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2. ZGD is a postdoctoral student and TZ is senior professors at the University of KwaZulu-Natal. A novel coronavirus from patients with pneumonia in China The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Coronavirus disease (COVID-2019) situation reports. Geneva: World Health Organization COVID-19 situation update worldwide, as of week 2 Prevalence and risk factors of mortality among hospitalized patients with COVID-19: a systematic review and Meta-analysis. Bull World Health Organ Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis Clinical characteristics and risk factors for fatal outcome in patients with 2019-coronavirus infected disease (COVID-19) in Wuhan Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis Measuring inconsistency in meta-analyses Comparison of two methods to detect publication bias in meta-analysis Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan China Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study Risk factors for hospitalization and mortality due to COVID-19 in Espírito Santo State, Brazil Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Demographics, comorbidities and outcomes in hospitalized Covid-19 patients in rural southwest Georgia Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: a retrospective observational study Demographics, comorbidities, and outcomes in hospitalized Covid-19 patients in Rural Southwest Georgia Hospitalization and mortality among black patients and white patients with Covid-19 Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19 Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large dataset from Mexico Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality Risk factors for mortality in patients with COVID-19 in New York City Cardiovascular disease, drug therapy, and mortality in COVID-19 Fatal outcomes of COVID-19 in patients with severe acute kidney injury Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet Risk factors for mortality and respiratory support in elderly patients hospitalized with COVID-19 in Korea Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Morbid obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50 Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis Risk factors associated with mortality among patients with COVID-19 in Intensive Care Units in Early predictors of clinical outcomes of COVID-19 outbreak in Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Predictors of mortality in adults admitted with COVID-19: retrospective cohort study from New York City Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China Risk factors for death in 1859 subjects with COVID-19 Distinct clinical characteristics and risk factors for mortality in female COVID-19 inpatients: a sex-stratified large-scale cohort study in Wuhan, China Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease Risk factors for mortality among COVID-19 patients Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China The risk of death in, novel coronavirus disease (COVID-19) in Hubei Province Well-aerated lung on admitting chest CT to predict adverse outcome in COVID-19 pneumonia Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan Clinical and laboratory predictors of in-hospital mortality in 305 patients with COVID-19: a Cohort Study in Wuhan Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations Elevated D-dimer levels are associated with increased risk of mortality in COVID-19: a systematic review and metaanalysis DPP4, the Middle East respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers • fast, convenient online submission • thorough peer review by experienced researchers in your field • rapid publication on acceptance • support for research data, including large and complex data types • gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year submit your research ? Choose BMC and benefit from: ? Choose BMC and benefit from: and chronic obstructive pulmonary disease patients Immunity to influenza: impact of obesity The immunopathogenesis of sepsis in elderly patients Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis Impact of smoking status on disease severity and mortality of hospitalized patients with COVID-19 infection: a systematic review and meta-analysis Sexual dimorphism in innate immunity Predictors of mortality in Middle East respiratory syndrome (MERS) Prevalence and impact of diabetes among people infected with SARS-CoV-2 Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life Obesity as a predictor for a poor prognosis of COVID-19: A systematic review Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study Successful and maladaptive T cell aging. Immunity The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire Considering how biological sex impacts immune responses and COVID-19 outcomes Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis Vidyadaran S. Gender effect on in vitro lymphocyte subset levels of healthy individuals Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study Clinical characteristics, associated factors, and predicting COVID-19 mortality risk: a retrospective study in Wuhan, China Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations We would like to thank the School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, South Africa for providing their guidance and support. Authors' contributions ZGD designed the study, extracted and analyzed the data, and wrote the article. TZ contributed to the idea and design of this study, advised on analysis and revised the manuscript. Both authors searched the literature. Both authors read and approved the final manuscript. No funding bodies played any role in the design, writing or decision to publish this manuscript. The dataset used and analyzed during the current study is available from the corresponding author on reasonable request. Ethics approval and consent to participate Not applicable. Not applicable. The authors declare that they have no competing interests.